Deep Tech Startups

Inimmune is a clinical-stage biotech company developing immunotherapies for allergy, cancer, infectious, and autoimmune diseases. The company combines immunology and vaccine expertise to advance its clinical and pre-clinical pipeline.

1 investor

iniVation develops neuromorphic vision technology for high-performance, low-power imaging systems serving both consumer and industrial applications.

1 investor

Inklusion designs immersive experiences using extended reality, digital twins, and artificial intelligence across training, games, and manufacturing applications.

1 investor

InkVivo Technologies develops polymer-based drug delivery platforms (GARD/gastroretentive and SHEALD/injectable) for controlled, localized, and sustained release of small molecules and biologics. An ETH Zurich spin-off, it works with pharmaceutical and nutraceutical partners to improve bioavailability and patient adherence, with programs targeting iron deficiency anemia and neurodegenerative diseases.

1 investor

Inmersia develops next-generation smart glasses called the Inmersia Lens, combining extended reality, AI, and 5G connectivity to replace traditional personal computing devices. The company targets users seeking sustainable and human-centered technology alternatives.

1 investor

Innogest is an investment firm that backs technology and healthcare companies, partnering with entrepreneurs.

1 investor

InnoPhase develops energy-efficient ORAN radio hardware for 5G infrastructure, built around a custom RF system-on-chip aimed at lowering total cost of ownership. Its technology targets wireless network operators and spans small cells to Massive MIMO arrays.

1 investor

Innophore builds Catalophore, a point-cloud technology that maps protein binding sites as multidimensional fingerprints to search across proteomes by the shape and chemistry of active sites. It offers software tools and computational discovery services for pharma and biotechnology, covering enzyme discovery, drug repurposing, off-target safety screening and protein engineering.

1 investor

Innorna develops mRNA-based therapeutics built on a proprietary platform featuring a lipid library of over 100,000 ionizable lipid structures and targeted LNP delivery systems. The company's pipeline spans vaccines, protein replacement therapies for chronic metabolic diseases, and in vivo immunotherapies for autoimmune conditions, with four candidates in clinical trials.

1 investor

Innospark is a venture capital firm that invests in AI-native companies and founders building technology-driven solutions across enterprise, healthcare, and physical-world applications. The firm focuses on companies leveraging artificial intelligence and computational technologies to solve complex problems.

1 investor

Innosphere is a technology economic development organization that operates incubators and venture capital programs focused on climate resilience, life sciences, and smart cities, serving early-stage companies and communities across the Mountain Plains region.

1 investor

InnoSyn produces recombinant pig liver esterase enzymes and screening kits for use in organic chemistry applications, particularly for asymmetric synthesis and racemic resolution of chiral compounds. The company supplies these biotech research products to pharmaceutical and chemical synthesis professionals.

1 investor

Innov+ is an independent validation and homologation provider for driver and occupant monitoring systems (DMS/OMS), offering a toolchain called Trusty that combines hardware, software, and data expertise for real-world performance testing. It serves automotive OEMs and Tier-1 suppliers, helping them meet regulatory standards such as Euro NCAP, GSR2, DDAW, and ADDW.

1 investor

Innventure sources promising technologies from multinational corporations' R&D and builds, funds, and operates them as standalone companies, using a MATCH quality scoring method to evaluate commercialization potential. It focuses on licensing or acquiring underused corporate IP and transforming it into scalable businesses.

1 investor

InovisCoat is a chemistry and process-engineering contract-coating company that develops coating chemistry, produces pastes, and applies up to seven simultaneous functional layers to substrates such as film, paper, and textile. A spin-off of AGFA Leverkusen, it serves industries including optical films (e.g. OLEDs), pharmaceutical and medical technology, security technology, and energy systems, handling volumes from research batches to mass production.

1 investor

Inphred develops visible and short-wave infrared (SWIR) cavity-based light emitters, including resonant-cavity LEDs and SWIR VCSELs manufactured on InP telecom foundries. Its components target sensing, health, datacom, LiDAR, and optical interconnect applications.

1 investor

InProcess-LSP manufactures nanoparticle size analyzers for real-time inline monitoring and non-destructive measurements in closed containers, serving pharmaceutical, biotech, and manufacturing companies conducting process development and quality control workflows.

1 investor

Inquis Medical is a medical device company developing minimally invasive technology to treat thromboembolic disease in the cardiovascular and vascular space. The company is led by a team of medtech entrepreneurs and physicians with experience in endovascular and interventional cardiology devices.

1 investor

InReality is a content authenticity and provenance platform that uses cryptographic signing to make photos, videos, and live streams verifiable as real. It secures content from capture through editing, sharing, and publication, creating a provenance record that proves media has not been manipulated or AI-generated.

1 investor

INSiAVA designs and develops specialised integrated circuits, including silicon light emitting technology integrated into standard CMOS processes as well as analogue and mixed-signal ICs for power and sensor markets. Originally spun out of the University of Pretoria in South Africa, it sells semiconductor products and IP to customers globally.

1 investor

Inside Therapeutics develops products and formulation systems for the biotech and pharmaceutical sector, distributed through a global network of scientific-instrument partners. Its product TAMARA is sold internationally via regional distributors across North America, Europe, Asia-Pacific, and South America.

1 investor

A publication covering deep tech developments, including coverage of autonomous racing where teams use identical hardware (NVIDIA RTX 6000 Ada GPU and 16-core AMD EPYC CPU) and compete on software performance.

1 investor

Insignito is a deep-tech company specializing in drone acoustics, whose DUMBO product uses passive long-range acoustic sensing and AI-driven analysis to detect drones (including RF-silent and tethered UAS) and filter out false alarms as part of a counter-UAS stack. It serves defense and security programs for applications such as border and perimeter security, critical infrastructure protection, and tactical force protection.

1 investor

InSpace provides a ground station platform with real-time data processing and GEOINT algorithms for satellite image analysis and dashboard management. The platform serves organizations requiring satellite data processing and geospatial intelligence services.

1 investor